Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Remuzzi

Showing results (101-110 of 546) with videos related to

Pageof 55
Sort By:
Kidney International|December 15, 2000
Repairing renal lesions: will VEGF be the builder?G Remuzzi, A Benigni
Pediatric Nephrology (Berlin, Germany)|August 1, 1995
Role of platelets in progressive glomerular diseasesC Zoja, G Remuzzi
European Journal of Haematology|April 1, 1996
The pathophysiology and management of thrombotic thrombocytopenic purpuraP Ruggenenti, G Remuzzi
Experimental Nephrology|November 1, 1995
Immunotolerance: from new knowledge of mechanisms of self-tolerance to future perspectives for induction of renal transplant toleranceG Remuzzi, N Perico
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?A Benigni, G Remuzzi
American Journal of Hematology|February 1, 1993
Low-dose aspirin and bleeding in uremiaG Viganò, G Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1996
Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomyP Ruggenenti, G Remuzzi
Current Opinion in Nephrology and Hypertension|November 18, 1998
Angiotensin II receptor antagonists and treatment of hypertension and renal diseaseN Perico, G Remuzzi
Kidney International|November 30, 2007
Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetesN Perico, G Remuzzi
Clinical and Experimental Immunology|December 12, 2007
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritisM Noris, G Remuzzi
Pageof 55

Showing results (101-110 of 546) with videos related to

Sort By:
Pageof 55
Kidney International|December 15, 2000
Repairing renal lesions: will VEGF be the builder?G Remuzzi, A Benigni
Pediatric Nephrology (Berlin, Germany)|August 1, 1995
Role of platelets in progressive glomerular diseasesC Zoja, G Remuzzi
European Journal of Haematology|April 1, 1996
The pathophysiology and management of thrombotic thrombocytopenic purpuraP Ruggenenti, G Remuzzi
Experimental Nephrology|November 1, 1995
Immunotolerance: from new knowledge of mechanisms of self-tolerance to future perspectives for induction of renal transplant toleranceG Remuzzi, N Perico
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 3, 1998
Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?A Benigni, G Remuzzi
American Journal of Hematology|February 1, 1993
Low-dose aspirin and bleeding in uremiaG Viganò, G Remuzzi
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 1996
Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomyP Ruggenenti, G Remuzzi
Current Opinion in Nephrology and Hypertension|November 18, 1998
Angiotensin II receptor antagonists and treatment of hypertension and renal diseaseN Perico, G Remuzzi
Kidney International|November 30, 2007
Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetesN Perico, G Remuzzi
Clinical and Experimental Immunology|December 12, 2007
Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritisM Noris, G Remuzzi
Pageof 55